Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hangzhou Oz-Biomedical Technology is a biotechnology company based in Hangzhou, China, specializing in the development and production of high-quality recombinant proteins and antibodies for the life sciences industry. The company provides a comprehensive suite of products and services, including diagnostic raw materials, protein engineering, and custom antibody discovery for pharmaceutical and research applications. Utilizing advanced mammalian and microbial expression systems, Oz-Biomedical supports the upstream requirements of drug development and in vitro diagnostics (IVD). The firm positions itself as a critical supplier and service provider for global biopharmaceutical companies and clinical diagnostic laboratories.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hangzhou Oz-Biomedical Technology.